These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16125173)

  • 1. Severe chronic experimental autoimmune uveitis (EAU) of the C57BL/6 mouse induced by adoptive transfer of IRBP1-20-specific T cells.
    Shao H; Liao T; Ke Y; Shi H; Kaplan HJ; Sun D
    Exp Eye Res; 2006 Feb; 82(2):323-31. PubMed ID: 16125173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the interaction of leukotriene b4 with its receptor prevents development of autoimmune uveitis.
    Liao T; Ke Y; Shao WH; Haribabu B; Kaplan HJ; Sun D; Shao H
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1543-9. PubMed ID: 16565390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis.
    Peng Y; Han G; Shao H; Wang Y; Kaplan HJ; Sun D
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4153-61. PubMed ID: 17724201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice.
    Cortes LM; Mattapallil MJ; Silver PB; Donoso LA; Liou GI; Zhu W; Chan CC; Caspi RR
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1946-56. PubMed ID: 18436827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivation of uveitogenic T cells by retinal astrocytes derived from experimental autoimmune uveitis-prone B10RIII mice.
    Jiang G; Ke Y; Sun D; Han G; Kaplan HJ; Shao H
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):282-9. PubMed ID: 18172104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activation of CD8 interphotoreceptor retinoid-binding protein-specific T cells requires not only antigenic stimulation but also exogenous growth factors.
    Peng Y; Shao H; Ke Y; Zhang P; Xiang J; Kaplan HJ; Sun D
    J Immunol; 2006 Apr; 176(8):5006-14. PubMed ID: 16585597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.
    Avichezer D; Silver PB; Chan CC; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):127-31. PubMed ID: 10634611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of established experimental autoimmune uveitis by anti-LFA-1alpha Ab.
    Ke Y; Sun D; Zhang P; Jiang G; Kaplan HJ; Shao H
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2667-75. PubMed ID: 17525198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2Y2R deficiency attenuates experimental autoimmune uveitis development.
    Relvas LJ; Makhoul M; Dewispelaere R; Caspers L; Communi D; Boeynaems JM; Robaye B; Bruyns C; Willermain F
    PLoS One; 2015; 10(2):e0116518. PubMed ID: 25692550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis.
    Keino H; Takeuchi M; Usui Y; Hattori T; Yamakawa N; Kezuka T; Sakai JI; Usui M
    Br J Ophthalmol; 2007 Jan; 91(1):105-10. PubMed ID: 16943228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a New Epitope of IRBP That Induces Moderate to Severe Uveoretinitis in Mice With H-2b Haplotype.
    Mattapallil MJ; Silver PB; Cortes LM; St Leger AJ; Jittayasothorn Y; Kielczewski JL; Moon JJ; Chan CC; Caspi RR
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5439-49. PubMed ID: 26284549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-IRBP IgG1 and IgG2a response does not correlate with susceptibility to experimental autoimmune uveitis.
    de Moraes LV; Martins GA; Flangini M; Ibañez OM; Sant'Anna OA; Rizzo LV
    Braz J Med Biol Res; 2006 Jun; 39(6):773-83. PubMed ID: 16751983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parental Uveitis Influences Offspring With an Increased Susceptibility to the Experimental Autoimmune Uveitis.
    Yin G; Zeng W; Hu K; Gao J; Liu J; Chen Y; Chen F
    Front Immunol; 2020; 11():1053. PubMed ID: 32612602
    [No Abstract]   [Full Text] [Related]  

  • 14. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
    Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
    Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interphotoreceptor retinoid-binding protein (IRBP)-deficient C57BL/6 mice have enhanced immunological and immunopathogenic responses to IRBP and an altered recognition of IRBP epitopes.
    Avichezer D; Liou GI; Chan CC; Lewis GM; Wiggert B; Donoso LA; Nickerson JM; Crawford MA; Caspi RR
    J Autoimmun; 2003 Nov; 21(3):185-94. PubMed ID: 14599843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of ACAID to suppress interphotoreceptor retinoid binding protein-induced experimental autoimmune uveitis.
    Hara Y; Caspi RR; Wiggert B; Chan CC; Streilein JW
    Curr Eye Res; 1992; 11 Suppl():97-100. PubMed ID: 1424755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAM receptor knockout mice are susceptible to retinal autoimmune induction.
    Ye F; Li Q; Ke Y; Lu Q; Han L; Kaplan HJ; Shao H; Lu Q
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4239-46. PubMed ID: 21467176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of interphotoreceptor retinoid-binding protein (IRBP)-specific Th1 and Th17 cells in anterior chamber-associated immune deviation (ACAID).
    Cui Y; Shao H; Sun D; Kaplan HJ
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5811-7. PubMed ID: 19458338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1 release triggered by the interaction of live retinal cells and uveitogenic T cells is Fas/FasL activation-dependent.
    Jiang G; Wang Y; Yun J; Hajrasouliha AR; Zhao Y; Sun D; Kaplan HJ; Shao H
    J Neuroinflammation; 2015 Sep; 12():179. PubMed ID: 26394985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD137 mAb treatment inhibits experimental autoimmune uveitis by limiting expansion and increasing apoptotic death of uveitogenic T cells.
    Shao H; Fu Y; Liao T; Peng Y; Chen L; Kaplan HJ; Sun D
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):596-603. PubMed ID: 15671287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.